U.S. Markets close in 2 hrs 32 mins

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
74.989+0.799 (+1.076%)
As of 1:28PM EDT. Market open.
People also watch
CELGBIIBAMGNBMYREGN
Full screen
Previous Close74.190
Open75.430
Bid75.210 x 200
Ask75.220 x 200
Day's Range74.650 - 75.990
52 Week Range63.760 - 82.100
Volume8,594,625
Avg. Volume8,568,701
Market Cap97.99B
Beta0.96
PE Ratio (TTM)7.93
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.08 (2.82%)
Ex-Dividend Date2017-06-14
1y Target EstN/A
Trade prices are not sourced from all markets
  • Editor's Pick
    Yahoo Finance2 days ago

    Facebook earnings, Fed announcement — What you need to know in markets on Wednesday

    The Fed will be overshadowed on Wednesday by the continued parade of corporate earnings coming out this week.

    3
  • Gilead Sciences, Inc. (GILD) Stock Has Tremendous Potential Even Post-Rally
    InvestorPlace3 hours ago

    Gilead Sciences, Inc. (GILD) Stock Has Tremendous Potential Even Post-Rally

    For the past few months, Gilead Sciences, Inc. (NASDAQ:GILD) could not fulfill the technical upside promise. Last night, GILD report earnings and the stock is spiking toward $76. Click to Enlarge Coming into the earnings, sentiment had also shifted in favor of better days to come from GILD stock, and I am one who likes to trade with the market sentiment.

  • Barrons.com3 hours ago

    Gilead Sciences: The Biggest of Beats?

    Shares of Gilead Sciences (GILD) are on the rise this morning after the biotech giant reported better-than expected earnings and revenue, and raised its product-sales guidance. Gilead reported a profit of $2.56 a share, beating forecasts for $2.29, on sales of $$7.1 billion, topping analyst expectations for $6.3 billion. Gilead also said that its net product sales would come in between $24.5 billion and 25.5 billion in 2017, up from a range of $22.5 billion to $24.5 billion.